- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Valiant Laboratories has published its audited financial results for the quarter ended June 30, 2025. The Board of Directors approved these results on August 8. For the quarter, standalone net profit was 1.82 Cr on total income of 51.68 Cr, turning around from a loss in the prior year. Consolidated net profit reached 1.82 Cr, with total income at 47.48 Cr, also marking a significant improvement from the previous year's loss. This indicates a strong return to profitability for the company. Basic EPS stands at ₹0.42.